2010-11-23 00:00:00,Vertex Completes New Drug Application For Telaprevir For Hepatitis C
2010-12-21 00:00:00,Vertex Provides Update To Ongoing Phase 2 Study Evaluating Combinations of Telaprevir And For Treatment Of Hepatitis C
2011-01-10 00:00:00,Vertex Issues FY 2010 Earnings Guidance Above Estimates
2011-01-20 00:00:00,Vertex Announces FDA And Health Canada Grant Priority Reviews For Telaprevir For The Treatment Of Hepatitis C
2011-03-02 00:00:00,Vertex Announces Positive Phase 2 Interim Data From First Study Of Telaprevir In People With Hepatitis C And HIV
2011-03-29 00:00:00,Vertex Announces Positive Results From A Analysis Of The Ongoing Phase 3 ENVISION Study Of
2011-03-31 00:00:00,Vertex Interim Phase 2 Data Rapid Viral Response To In Combination With And Ribavirin Among People With Hepatitis C
2011-05-04 00:00:00,Vertex Comments On FY 2012 Call
2011-05-23 00:00:00,Food and Drug Administration Approves Vertex INCIVEK Tablets For People With Hepatitis C
2011-06-13 00:00:00,Vertex And Alios BioPharma Announce Exclusive Worldwide Licensing Agreement for Two Nucleotide Drug Candidates
2011-06-22 00:00:00,Vertex Announces Data From Two Phase 3 Studies Of INCIVEK In Hepatitis C
2011-07-26 00:00:00,Vertex Announces Interim Data From Phase II Study of Combination Regimen Including and INCIVEK
2011-07-28 00:00:00,Vertex Comments On FY 2012 Earnings Call
2011-08-22 00:00:00,Vertex Announces Health Canada Approves INCIVEK For People With Hepatitis C
2011-09-06 00:00:00,Vertex Rheumatoid Arthritis Drug Meets Study
2011-11-03 00:00:00,Vertex Announces Data From First Part Of Phase 2 Study Support Approach Of Treating Common Form Of Cystic Fibrosis
2011-12-09 00:00:00,Vertex And Alios BioPharma Begin Clinical Studies Of Nucleotide Drug Candidates And For The Treatment Of Hepatitis C
2011-12-15 00:00:00,Vertex Announces CEO Succession Plan For 2012
2012-02-23 00:00:00,Vertex Pharmaceuticals Inc Announces Data And SVR4 From Phase 2 Study Of Treatment Regimen Of And Ribavirin
2012-03-06 00:00:00,Vertex Pharmaceuticals Inc Announces Interim Results From Ongoing Phase 2 Study Of INCIVEK
2012-07-16 00:00:00,Square Foot Lease Extension In San Diego Through 2018 Signed By Vertex Inc And BioMed Inc
2012-07-27 00:00:00,Vertex Pharmaceuticals Inc Receives European Approval For KALYDECO
2012-07-30 00:00:00,Vertex Pharmaceuticals Inc Announces Positive Results From Viral Kinetic Study Of Nucleotide Analogue In People With Hepatitis C
2012-09-07 00:00:00,Shareholder Rights Law Firm Johnson LLP Investigates Vertex Pharmaceuticals Inc For Securities Fraud
2012-10-09 00:00:00,Deutsche Bank Analysts Begin Coverage on Vertex Pharmaceuticals
2012-10-10 00:00:00,Levi LLP Announces Class Action Against Vertex Pharmaceuticals
2012-10-11 00:00:00,Vertex Pharmaceuticals Cystic Fibrosis Treatment Appears to Work in Study
2012-10-16 00:00:00,VERTEX PHARMACEUTICALS INCORPORATED Vertex Announces the Date
2012-10-18 00:00:00,Vertex Draws Collaboration Interest For Hepatitis C Combo
2012-10-22 00:00:00,Levi LLP Announces Class Action Against Vertex Pharmaceuticals
2012-10-24 00:00:00,Vertex Pharma Third Quarter Earnings Sneak Peek
2012-10-31 00:00:00,Vertex Pharmaceuticals Incorporated Investor Lawsuit
2012-11-01 00:00:00,A Hep C Love Triangle
